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ABSTRACT Solid-state hydrogen/deuterium exchange (ssHDX) with electrospray ionization mass spectrometry (ESI-MS) and
Fourier transform infrared (FTIR) spectroscopy were used to assess protein conformation in amorphous solids. Myoglobin,
lysozyme, b-lactoglobulin, ribonuclease A, E-cadherin 5, and concanavalin A were co-lyophilized with carbohydrates (trehalose,
rafﬁnose, and dextran 5000), linear polymers (polyvinyl alcohol and polyvinyl pyrrolidone) or guanidine hydrochloride (negative
control). For ssHDX, samples were exposed to D2O vapor at 33% relative humidity and room temperature, and then
reconstituted at low temperature (4C) and pH 2.5 and analyzed by ESI-MS. Peptic digestion of selected proteins was used to
provide region-speciﬁc information on exchange. FTIR spectra were acquired using attenuated total reﬂectance. FTIR and
ssHDX of intact proteins showed preservation of structure by rafﬁnose and trehalose, as indicated by FTIR band intensity and
protection from exchange. ssHDX of peptic digests further indicated that these protective effects were not exerted uniformly
along the protein sequence but were observed primarily in a-helical regions, a level of structural resolution not afforded by FTIR.
The results thus demonstrate the utility of HDX with ESI-MS for analyzing protein conformation in amorphous solid samples.
INTRODUCTION
Proteins and other biotech drugs are among the fastest-
growing sectors of the pharmaceutical industry. To protect
these labile molecules from chemical and physical degrada-
tion, protein drugs are often marketed as solids. The properties
of proteins and formulation additives (‘‘excipients’’) together
with the processing methods used (e.g., lyophilization) typi-
cally produce solids that are amorphous rather than crystalline.
Though amorphous solids are lower in energy than solutions,
there is ample evidence that proteins undergo a variety of
degradation processes in the amorphous solid state (1–4).
Understanding and controlling these processes is central to
the effective development of solid protein drug products.
Although the mechanisms of protein degradation in amor-
phous solids are far from clear, maintaining native conforma-
tion is generally considered critical for preventing degradation.
Various methods have been used to assess protein structure in
amorphous solids, though far fewer methods are available for
solid proteins than for proteins in solution. Themost commonly
used technique is Fourier transform infrared (FTIR) spectros-
copy. FTIR offers the advantages of applicability to both solid
and solution samples, ease of sample preparation, and rapid
analysis. However, although FTIR can detect gross changes in
protein secondary structure, the method lacks sufﬁcient reso-
lution to detect more subtle structural changes. Other spectro-
scopic methods, such as near-infrared circular dichroism and
Raman spectroscopy, and thermal methods such as differential
scanning calorimetry (DSC) also have been used to acquire
information on protein structure in amorphous solids but share
the limited resolution of FTIR. Solid-state nuclear magnetic
resonance spectroscopy (ssNMR) hasmade it possible to solve
the structures of membrane proteins at atomic resolution.
Current ssNMR methods allow the complete assignment of
backbone and side-chain signals for solid proteins in the 5–10
kDrange, but generally require that the sample possess a degree
of microscopic order (e.g., crystallinity) and/or isotopic label-
ing. Since protein drugs are often much larger than 10 kD, lack
microscopic order in the amorphous solid state, and are not
routinely expressed in isotopically enriched forms, the routine
application of current ssNMR methods to determine protein
drug conformation in amorphous solids is impractical.
Hydrogen/deuterium exchange (HDX) has emerged as a
new method for studying protein conformation and excipient
interactions in the solid state. In solution, HDX has been used
for more than 50 years to study protein conformation, fold-
ing, and ligand binding (5,6). Recently, efforts have beenmade
to extend HDX to proteins in the solid state. Generally, ly-
ophilized formulations are exposed to D2O vapor for variable
lengths of time at a predetermined relative humidity (RH) value
before being analyzed by a suitable technique. French et al. (7)
used HDX with FTIR analysis to characterize human granu-
locyte colony stimulating factor (rhG-CSF) and recombinant
consensus interferon-a (rConIFN) in spray-dried powders
containing trehalose, using isotopic shifts in the amide II/II9
bands. Desai et al. (8) employed HDX with 1H NMR analysis
to study the unfolding of bovine pancreatic trypsin inhibitor
(BPTI) on lyophilization. In previous studies by our group (9–
11), HDX with tandem liquid chromatography/electrospray
ionization mass spectrometry (LC/1ESI-MS) and peptic map-
ping were used to provide site-speciﬁc information on HDX
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in solid samples of calmodulin. The results demonstrated that
low-molecular-weight sugars (i.e., trehalose and sucrose)
provided signiﬁcant protection from exchange relative to
excipient-free controls, and that this protection was exerted
preferentially in the a-helical fragments. The studies presented
here extend this method to other model proteins and compare
the results with those obtained by FTIR. The work also tests
the hypothesis that protection from HDX by excipients in
amorphous solids is exerted nonuniformly along the protein
sequence and depends on excipient type and protein structure.
MATERIALS AND METHODS
Materials
Myoglobin, lysozyme, ribonuclease A, b-lactoglobulin, concanavalin A (see
Table 1), rafﬁnose, trehalose, polyvinyl alcohol (PVA; average molecular
weight of 30,000), polyvinyl pyrrolidone (PVP; average molecular weight of
10,000), tris[2-carboxyethyl] phosphine (TCEP), urea-d4, and guanidine
hydrochloride (GdnHCl) were obtained from Sigma-Aldrich (St. Louis,
MO). Dextran 5000 was obtained from Fluka (Milwaukee,WI). Isopropyl-b-
D-thiogalactopyranoside (IPTG) for protein expression was purchased from
Amresco (Solon, OH). Pepsin was obtained from Worthington Biochemical
Corp. (Lakewood, NJ) and formic acid was obtained from Acros Organics
(Morris Plains, NJ). All materials were of reagent grade or higher and used
without further puriﬁcation.
Expression and puriﬁcation of E-cadherin 5
E-cadherin 5 (EC5, Table 1) was expressed in Escherichia coli by trans-
forming the recombinant plasmid into BL21 (DE3)-T1R competent cells
according to a previously reported protocol (12). Brieﬂy, cells were incu-
bated in self-made LB agar plates with kanamycin as the inhibiting antibiotic.
A colony was selected and IPTG added to induce overexpression. After
further incubation, the cells were transferred to 4C to stop growth, pelleted,
reconstituted, and French-pressed to lyse the cells. The supernatant was
centrifuged and loaded onto a Q-Sepharose column connected to a fast
protein liquid chromatography (FPLC) system (Amersham Biosciences,
Piscataway, NJ). EC5 fractions were collected and concentrated using
AmiconUltra-15 tubes with a 5000-mol wt cutoff (Millipore Corp., Billerica,
MA). The concentrated protein was then further puriﬁed using a Superdex
200 column (GE Healthcare, Piscataway, NJ). EC5 concentration was de-
termined by UV absorption at 280 nm.
Sample preparation
Solid samples were prepared by lyophilization from aqueous solution. Then
100mL samples of protein in solution (4 mg/mL) were directly lyophilized or
colyophilized with one of the excipients (i.e., trehalose, rafﬁnose, dextran,
PVA, or PVP) in a ratio of 1:1 (w/w). For samples containing GdnHCl, 100
mL of a 3 M GdnHCl solution were added to the 100 mL protein solution
before lyophilization. All samples were lyophilized by ﬁrst freezing at
35C for 2 h. Drying was then performed under a vacuum of 15 mT at a
shelf temperature of35C for 2 h,5C for 8h, 5Cfor 6 h, and 25C for 10h.
Solids characterization
Lyophilized solids were analyzed to determine moisture content, glass
transition temperature (Tg), crystallinity, and protein secondary structure.
Thermogravimetric analysis
Thermogravimetric analysis (TGA) was used to measure the water content in
the lyophilized samples after exposure to 33% RH conditions for 72 h.
Samples were analyzed by a Q50 TGA (TA Instruments, New Castle, DE)
with a thermal scan from ambient to 200C at a scan rate of 10C/min in an
open platinum panwith nitrogen purge. Universal Analysis software (version
4.1, TA Instruments) was used to determine water content from the measured
mass loss.
DSC
DSC was used to determine the Tg of the lyophilized formulations after
exposure to 33% RH for 72 h. Modulated-temperature DSC (MTDSC) was
used to distinguish glass transition events from other kinetic thermal events,
such as dehydration and degradation, using a Q100 DSC (TA Instruments).
Samples were held isothermally at 25C for 5 min before increasing the
temperature at a ramp rate of 1C/min with modulation amplitudes of
60.32C and a modulation period of 60 s. Universal Analysis software
(version 4.1, TA Instruments) software was used for analysis.
Powder x-ray diffraction
Powder x-ray diffraction (PXRD) was performed to ascertain whether the
lyophilized samples were in the crystalline or the amorphous state after
exposure to 33% RH for 72 h. The lyophilized samples were packed into the
shallow cell of a plastic sample holder and covered with a glass slide. A
Bruker D8 Discover powder diffractometer with a solid-state detector (Bruker
AXS, Madison, WI) was used with Cu-Ka at a scan rate of 1.2 2u/min from
10 to 40. Crystallinity was assessed visually from the PXRD patterns.
FTIR spectroscopy
FTIR spectroscopy was performed to assess protein secondary structure in
lyophilized solids. A PerkinElmer FTIROne spectrometer (PerkinElmer Life
and Analytical Sciences, Waltham, MA) with a universal attenuated total
reﬂectance accessory (UATR) was used to acquire the spectra. The solid
sample was placed on a diamond crystal surface and covered with a stainless-
steel slide, and pressure (.100 Torr) was applied to ensure good contact
between the protein and the crystal. GRAM AI software (Thermo Electron
Corp., Waltham, MA) was used to analyze the spectra. The raw absorption
spectra (amide I band) were derivatized followed by area normalization using
the GRAMS software to enable direct qualitative and quantitative compar-
isons between spectra. Quantitation was performed using the method of
Kendrick et al. (13). Bands at;1660–1650 cm1 were assigned to a-helical
structures, and those at ;1640–1625 cm1 were assigned to b-sheet struc-
tures. Because the pyrrolidone ring of PVP absorbs in the amide I region,
masking the protein signal, FTIR measurements were not performed on
samples containing PVP. FTIR spectra were not acquired for samples
GdnHCl due to partial crystallization.
Solid-state HDX
Solid-state HDX (ssHDX) experiments were performed according to the
protocol previously reported by our group (9,10). Lyophilized samples were
placed in sealed desiccators at room temperature and 33% RH over D2O,
achieved by storing the samples over a saturated solution of MgCl2 in D2O.
Samples were collected in triplicate at designated times for immediate
analysis or stored at –80C for later analysis. ssHDX experiments were
performed for intact protein and for peptic digests, as described below.
ssHDX for intact protein
ssHDX studies of intact protein were performed to determine the total deu-
terium uptake by the protein upon exposure to D2O vapor at 33% RH for
72 h. Preliminary data (not shown) and our previous studies (9,10) showed
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that proteins generally reach a plateau in deuterium uptake after 72 h at 33%
RH; this standard storage time was applied to all proteins. Lyophilized for-
mulations were reconstituted with solvent A (94.5% H2O, 5% acetonitrile,
and 0.5% formic acid, pH 2.3) to a protein concentration of 4 mg/mL. A 2mL
aliquot was then removed and diluted with an additional 48 mL of solvent
A. The sample was then injected into a short C18 trap column (Upchurch
Scientiﬁc, Oak Harbor, WA) and washed with the aqueous phase for 1.3 min
before being eluted with solvent B (19.5% H2O, 80% acetonitrile, and 0.5%
formic acid) into the mass spectrometer. A Micromass Q-Tof II mass spec-
trometer (Waters Corp., Milford, MA) was used in1ESI mode for analysis.
The intact protein was detected within 3 min after reconstitution. MassLynx
software (version 4.0, Waters Corp.) was used to deconvolute the mass
spectrum for the intact molecules, and the mass was taken as the centroid of
each deconvoluted peak. Back exchange was corrected using the method of
Zhang and Smith (14), and total deuterium incorporation (D) was calculated as
D ¼ ½ðm moÞ=ðm100  moÞ3N; (1)
where m is the mass of the sample protein at any time, mo is the mass of the
native protio form of the protein, m100 is the mass of the fully deuterated
protein, and N is the total number of exchangeable amides on the protein
backbone. The protection (P) from exchange provided by a particular
excipient is deﬁned as the difference between the percent deuterium incor-
poration for an excipient-free control (Dn) and the percent deuterium
incorporation for the excipient-containing sample (De), (i.e., P ¼ Dn  De).
ssHDX of peptic digests
Solid samples of selected proteins (i.e., EC5, b-lactoglobulin, and myoglo-
bin) were subjected to proteolytic digestion with pepsin to determine the
distribution of deuterium incorporation along the protein sequence. Lyoph-
ilized pepsin was dissolved in 10 mM sodium acetate to a ﬁnal concentration
of 15 mg/mL. For each digestion, lyophilized proteins without disulﬁde
bonds (i.e., myoglobin) were reconstituted with 40mL solvent A followed by
the addition of 12 mL pepsin (1:3, protein/pepsin w/w). Proteins with di-
sulﬁde bonds (i.e., EC5 and b-lactoglobulin) were reconstituted with 35 mL
1M TCEP/4M urea-d4 solution (15) and placed in an ice bath for 4 min to
denature the protein and reduce the disulﬁde bonds before the addition of
12 mL of pepsin solution. In either case (i.e., proteins with or without di-
sulﬁde bonds), the mixture was introduced into the injection loop (on ice) and
digestion was allowed to occur online for 3 min before LC1ESI-MS. The
peptides were separated on a C4 reverse phase column (Grace Vydac,
Hesperia, CA) with a gradient from 5% to 50% B in 7 min followed by a
wash and reequilibration step. Data analysis was performed using the MS
scan with the highest ion count; the cluster was then smoothed and cen-
tralized to calculate the deuterium uptake after correcting for back exchange
by the method of Zhang and Smith (14). The injection port, column, and
tubing were kept on ice and low pH solvents were used to minimize back
exchange. Deuterium incorporation for each peptic fragment was calculated
relative to the deuterated control (see Eq. 1). Back exchange is assumed to
be independent of fragment secondary structure or corrected by the use of
deuterated controls, as is typical in solution HDX studies (16,17) and as
observed in our previous ssHDX studies on calmodulin (9).
RESULTS
Physical characterization of solids
Solid samples were subjected to thermal analysis (DSC and
TGA) and x-ray diffraction (PXRD) to establish the physical
state (i.e., amorphous versus crystalline) and measure key
physical properties (i.e., Tg and water content). PXRD pat-
terns for all samples were consistent with amorphous mate-
rial, with the exception of samples treated with GdnHCl,
which showed partial crystallinity (not shown). TGA and
DSC were performed for samples containing various excip-
ients and either myoglobin (a representative a-helical pro-
tein) or b-lactoglobulin (a representative b-sheet protein).
Regardless of the excipient used, water content did not ex-
ceed 8% (Table 2), and was highest in dextran and PVP
formulations. DSC studies were performed on amorphous
formulations to determine Tg. For myoglobin, Tg values in-
creased in the order PVA, trehalose, rafﬁnose, dextran,
PVP, whereas for b-lactoglobulin the order was trehalose ,
PVA, rafﬁnose, dextran; PVP (Table 2). Tg values were
.40C in all cases, indicating that the solids are in the glassy
state at the temperature of the FTIR and ssHDX studies (room
temp. ;25C).
The solids-characterization studies thus establish that, with
the exception of formulations containing GdnHCl, the myo-
globin and b-lactoglobulin samples are glassy amorphous
solids with a moisture content of ;4–8%. Samples contain-
ing GdnHCl are partially crystalline with a moisture content
of 4–8%. The properties of samples containing other proteins
are assumed to be similar.
Protein conformation in amorphous solids by
FTIR and ssHDX
Amide I FTIR spectra and ssHDX data were acquired for six
proteins with different secondary structures. Data are grouped
by protein and ordered from proteins with the greatest a-helix
content to those with the greatest b-sheet content. Within
each protein, FTIR data are presented ﬁrst followed by
ssHDX data for the intact (i.e., undigested) protein. When
available, ssHDX data for peptic digests are then presented.
Myoglobin
Myoglobin is a globular protein with high (83%) a-helix
content (Table 1). The a-helical structure is retained in
samples lyophilized in the absence of excipients, as reﬂected
in the strong FTIR bands at 1660 and 1650 cm1 (Fig. 1 A).
The band intensity is greater for solid samples containing
trehalose or rafﬁnose, consistent with an increase in a-helix
content and greater retention of structure. FTIR spectra for
samples containing dextran were similar to the excipient-free
samples, whereas those containing PVA showed a loss in
a-helix band intensity relative to controls, consistent with a
loss in structure. Changes in intensity of the unstructured
band (;1640 cm1) mirror changes in the a-helix band. Peak
assignments are in agreement with previous FTIR reports for
myoglobin (18–20).
ssHDX results for intact myoglobin (i.e., not subjected to
peptic digestion) show a pattern of exchange consistent with
the FTIR results (Fig. 1 B). The greatest protection from
exchange was observed for samples containing trehalose
and rafﬁnose, and these samples also showed the strongest
a-helix band intensity on FTIR (Fig. 1 A). Exchange was
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greater for samples containing PVA or excipient-free sam-
ples, in agreement with weak FTIR a-helix band intensities.
The loss of FTIR band intensity at 1650 cm1 for samples
containing PVA relative to excipient-free controls is not re-
ﬂected in higher exchange, however. Samples containing
dextrose showed intermediate a-helix band intensity and
extent of exchange. LC/1ESI-MS spectra of myoglobin
showed evidence of dimer formation (;4%) after storage at
33% RH for 72 h.
ssHDX was also performed for myoglobin after peptic
digestion. Digestion produced 28 fragments detectable by
LC/1ESI-MS, 13 of which were selected to provide maxi-
mum sequence coverage (74%; Fig. 1 C). Rafﬁnose and
trehalose showed the greatest protection from exchange for
all fragments, consistent with ssHDX results for the intact
protein. As in our previous studies of calmodulin (9–11), the
greatest protective effect of these sugars was observed for the
a-helical fragments (fragments 2–9 and 12; Fig. 1 C). Most
of the unstructured fragments also showed some protective
effect (fragments 1, 10, 11, and 13; Fig. 1 C). Although these
fragments were assigned to the ‘‘unstructured’’ group, all but
FIGURE 1 Myoglobin conformation in amorphous solids containing various additives (1:1 w/w). (A) Second derivative FTIR spectra. (B) ssHDX of intact
protein. (C) ssHDX of peptic digests. Additives were trehalose (Tre), rafﬁnose (Raf), dextran (dex), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), and
guanidine hydrochloride (Gdn). In C, peptic fragments and approximate secondary structures were: 1 (G1-W7; 42% a-helix), 2 (Q8-L11; 100% a-helix), 3
(N12-A19; 67% a-helix, 33% turn), 4 (I21-L29, 100% a-helix), 5 (I30-L40, 100% a-helix), 6 (G35-L40, 100% a-helix), 7 (M55-L69, 100% a-helix), 8 (T70-
L76, 100% a-helix), 9 (G80-L86, 71% a-helix), 10 (K87-Y103, 47% a-helix), 11 (A110-D126, 52% a-helix, 17% turn), 12 (I142-K147, 100% a-helix), and
13 (L149-G153, 20% a-helix). In B, asterisk indicates signiﬁcant difference from the value for the ‘‘None’’ sample (a ¼ 0.05); n ¼ 3 6 SD.













Myoglobin 16.95 0 83 0 17
Lysozyme 14.3 4 40 6 54
Ribonuclease A 13.7 4 27 38 35
b-Lactoglobulin 18.3 2 12 35 53
E-Cadherin 12.6 2 7 30 60
Concanavalin A 25.6 0 7 79 14
Source—RCSB PDB: myoglobin (1WLA), lysozyme (1CXV), RNase A
(1RBX), b-lactoglobulin (1CJ5), concanavalin A (1GKB). EC5 information
from reports in literature (12).
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fragment 13 had some a-helix content (Fig. 1 C). Dextran
exhibited amoderate protective effect primarily in thea-helical
fragments, whereas PVA and PVP showed no protective
effects in any fragment.
As expected, the greatest deuterium incorporation oc-
curred in myoglobin samples exposed to GdnHCl. For some
fragments (fragments 4–8, 11, and 12; Fig. 1 C) deuterium
incorporation was .100% in solid samples treated with
GdnHCl. Since the percent deuterium incorporation is cal-
culated relative to the fully folded and fully deuterated pro-
tein in solution (see Eq. 1), values .100% suggest that the
protein was denatured in GdnHCl solutions, remained un-
folded upon lyophilization, and in that form showed greater
deuterium uptake from D2O(g) in the solid protein than in the
native protein in D2O solution. Of the proteins subjected to
digestion, this effect was only observed for myoglobin.
Lysozyme
Lysozyme’s mixed a-helix and b-sheet structure (Table 1) is
reﬂected in the FTIR spectra of solid samples. FTIR spectra
for samples without excipients showed moderately strong
a-helix bands at 1658 and 1648 cm1 together with strong
b-sheet bands at 1638 cm1 (Fig. 2 A), consistent with pre-
vious reports (19,21). In samples containing excipients, the
a-helix bands show modest increases in intensity (versus
‘‘none’’) indicative of increased secondary structure (22).
Samples containing trehalose or PVA also showed modest
increases in b-sheet band intensity (1638 cm1). Lysozyme
has been reported to undergo structural perturbation on
drying, leading to loss of secondary structure (23).
ssHDX studies of intact lysozyme (Fig. 2 B) showmoderate
protection from exchange by trehalose, rafﬁnose, and dextran
with little protection by PVA and PVP. Lysozyme and other
proteins with disulﬁde bonds showed lower percentage deu-
terium uptake after GdnHCl exposure (i.e., lysozyme, ribo-
nuclease A, b-lactoglobulin; Figs. 2 B, 3 B, and 4 B, Table 1).
This suggests that the disulﬁde bonds, which were not reduced
here, provided some protection from exchange after GdnHCl
treatment. Since lysozyme could not be digested quickly with
pepsin, ssHDX studies of peptic digests were not performed.
RNase A
RNase A is an endonuclease with mixed a-helix and b-sheet
structure (Table 1). The dominant feature of the FTIR spectra
for solid samples is a strong b-sheet band (;1638 cm1) that
increases in intensity when excipients are included (Fig. 3 A).
Weak a-helix bands are also observed at 1658 and 1650
cm1; the latter shows minor increases in intensity for sam-
ples containing PVA or dextran. Peak assignments are
in agreement with previous FTIR studies of RNase A
(18,19,24,25).
ssHDX studies of intact RNase A show moderate protec-
tion from exchange by trehalose and rafﬁnose, with little
protection by the other excipients (Fig. 3 B). This pattern is
not consistent with the effects of the excipients on the b-sheet
and a-helix bands of the FTIR spectrum (see Discussion). As
was the case with lysozyme, RNase A could not be digested
TABLE 2 Moisture content and Tg values for myoglobin and b-lactoglobulin formulations*
Additive
Protein Property Trehalose Rafﬁnose Dextran PVA PVP None
Myoglobin Moisture content (%) 4.53 6 0.25 4.42 6 0.09 6.11 6 0.79 5.12 6 0.2 7.00 6 0.85 3.94 6 0.64
Tg (C) 52.41 6 0.98 56.18 6 0.52 95.06 6 0.95 41.72 6 0.49 96.3 6 2.09 NA
b-Lactoglobulin Moisture content (%) 6.18 6 0.38 5.67 6 0.24 7.23 6 0.23 4.68 6 0.59 6.32 6 0.78 6.85 6 0.44
Tg (C) 43.53 6 0.58 47.34 6 2.17 94.93 6 0.58 44.41 6 0.06 94.69 6 0.50 NA
*After exposure to 33% RH, 72 h. Protein/excipient ¼ 1:1 (w/w).
FIGURE 2 Lysozyme conformation in amorphous solids containing var-
ious additives (1:1 w/w). (A) Second derivative FTIR spectra. (B) ssHDX of
intact protein. Additives were Tre, Raf, dex, PVA, PVP, and Gdn. In B,
asterisk indicates signiﬁcant difference from the value for the ‘‘None’’
sample (a ¼ 0.05); n ¼ 3 6 SD.
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quickly with pepsin, so ssHDX studies of peptic digests were
not performed.
b-lactoglobulin
b-lactoglobulin is a lipocalin with mixed a-helix and b-sheet
structure (Table 1). FTIR spectra of solid samples showed
a strong band at 1626 cm1 assigned to b-sheet (Fig. 4 A).
The position and intensity of this band are relatively unaf-
fected by the carbohydrate excipients, whereas inclusion of
PVA is associated with a decrease in its intensity. Although
b-lactoglobulin has some a-helix content (Table 1), these
bands are not prominent in the FTIR spectra of the solid
samples. The spectra are in good agreement with those pre-
viously reported for b-lactoglobulin (24).
As for RNase A, ssHDX results for the intact b-lacto-
globulin show signiﬁcant protection from exchange by tre-
halose and rafﬁnose, more limited protection by dextran, and
little to no protection by PVA and PVP (Fig. 4 B). Although
trehalose and rafﬁnose show protection from exchange, in-
clusion of these excipients had little effect on the FTIR
spectum.
ssHDX analysis of peptic digests of b-lactoglobulin was
also conducted. Sixteen of the 32 peptic fragments detected
by LC/1ESI-MS were used to map the protein (Fig. 4 C),
providing 76% sequence coverage. The b-sheet regions of
b-lactoglobulin generally showed lower deuterium incorpo-
ration than other types of secondary structure, and values
were less sensitive to excipient type (Fig. 4 C). Protection
from exchange in the a-helical fragments followed the pat-
tern observed for myoglobin, with the greatest protection
provided by trehalose and rafﬁnose. Exchange in fragments
assigned to the ‘‘mixed’’ or ‘‘loops and other’’ categories
was variable. In some fragments, inclusion of PVA or PVP
resulted in greater deuterium incorporation than in the ex-
cipient-free control (e.g., fragments 1, 12, 13, and 16; Fig.
4 C), suggesting that PVA and PVP promote exposure to
D2O(g) in these fragments.
EC5
EC5 is a domain of the adhesion protein E-cadherin with high
b-sheet content. FTIR spectra for EC5 show a strong b-sheet
band at 1644 cm1, suggesting that the b-sheet structure is
retained in the solid samples (Fig. 5 A). The spectrum is
relatively unaffected by the inclusion of excipients. ssHDX
studies of intact EC5 showed high deuterium incorporation
that was insensitive to excipient type (Fig. 5 B), consistent
with the FTIR results.
ssHDXwas performed on peptic digests of EC5 (Fig. 5C).
Eleven peptic fragments were selected for analysis, giving
a total sequence coverage of 97%, and assigned to either
b-sheet or unstructured regions (Fig. 5 C). Fragments with
partial b-sheet character (i.e., fragments 1, 3, and 4; Fig. 5 C)
were included in the unstructured group on the basis of their
exchange behavior. Peptic fragments of EC5 generally
showed greater percent deuterium incorporation than ob-
served for other proteins, suggesting a less compact structure
in the solid state. The b-sheet fragments (fragments 2 and
5–9; Fig. 5 C) showed some protection from exchange by the
various excipients, to a degree roughly comparable to the
b-sheet regions of b-lactoglobulin (Fig. 5 C). The unstruc-
tured fragments of EC5 were insensitive to excipient type,
and exposure to GdnHCl did not increase deuterium incor-
poration relative to the other excipients (fragments 1, 3, 4, 10,
and 11; Fig. 5 C), again suggesting a loose structure.
Con A
Con A is a lectin with a predominantly b-sheet structure
(Table 1). FTIR spectra for solid samples of Con A show an
intense b-sheet band at 1633 cm1, consistent with retention
of secondary structure (Fig. 6 A). Relative to the excipient-
free control, the intensity of the band increases in solids
containing trehalose or rafﬁnose with a corresponding de-
crease in the shoulder at ;1625 cm1, suggesting increased
secondary structure. The spectrum is relatively insensitive to
FIGURE 3 RNase conformation in amorphous solids containing various
additives (1:1 w/w). (A) Second derivative FTIR spectra. (B) ssHDX of
intact protein. Additives were Tre, Raf, dex, PVA, PVP, and Gdn. In B,
asterisk indicates signiﬁcant difference from the value for the ‘‘None’’
sample (a ¼ 0.05); n ¼ 3 6 SD.
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other excipients. Peak assignments agree with previous FTIR
reports for Con A (18).
ssHDX studies of intact Con A showed a pattern of ex-
change consistent with the FTIR results (Fig. 6 B). The
greatest protection from exchange was observed for trehalose
and rafﬁnose, whereas other excipients showed more modest
effects. Protection from deuterium exchange was generally
more limited for Con A than for other proteins. Of interest,
Con A showed relatively low deuterium incorporation on
ssHDX after exposure to GdnHCl, although the protein
contains no disulﬁde bonds. Con A forms dimers, tetramers,
and aggregates in aqueous solution (26), which may be re-
tained during lyophilization and may protect the GdnHCl-
treated protein from deuterium exchange in the solid state.
Unlike the other proteins, solids containing Con A were hazy
upon reconstitution, further supporting the presence of aggre-
gation and/or oligomerization. LC/1ESI-MS spectra showed
peaks corresponding to dimeric and trimeric forms of Con A
after exposure to 33% RH for 72 h. The areas of these decon-
volutedMS peaks were;8% and 4%, respectively, of the area
of intact Con A. Con A could not be digested quickly with
pepsin, so ssHDX studies of peptic digestswere not performed.
Statistical analysis
For each protein, FTIR spectra for samples containing ex-
cipients were compared quantitatively with those for the
excipient-free control using the ‘‘area of overlap’’ method of
Kendrick et al. (13) (Table 3), which compares spectra on the
basis of the fraction of overlapping area in area-normalized
second derivative spectra. All matrix entries were $0.90,
indicating that the spectra for samples containing excipients
are very similar to those of the excipient-free controls (13).
In ssHDX studies of intact protein, deuterium incorpora-
tion in samples containing excipients was compared with that
in excipient-free controls using one-way analysis of variance,
with Tukey’s test for post hoc comparison of the means
(Origin 7.0, OriginLab Corp., Northampton, MA). Differ-
ences in percent exchange of 2–3%were generally signiﬁcant
at 95% conﬁdence (a ¼ 0.05; see part B in Figs. 1–6).
FIGURE 4 b-Lactoglobulin conformation in amorphous solids containing various additives (1:1 w/w). (A) Second derivative FTIR spectra. (B) ssHDX of
intact protein. (C) ssHDX of peptic digests. Additives were Tre, Raf, dex, PVA, PVP, and Gdn. In C, peptic fragments and approximate secondary structures
were: 1 (V3-D11, 11% a-helix, 27% turn), 2 (I12-W19, 50% a-helix), 3 (Y20-M24, 100% b-sheet), 4 (I29-V32, 75% turn), 5 (D33-V41, 22% turn), 6 (Y42-
L54, 61.5% b-sheet), 7 (L46-L54, 44% b-sheet), 8 (K75-F82, 25% b-sheet, 25% turn), 9 (N90-L95, 83% b-sheet), 10 (D96-L104, 22% b-sheet), 11 (N109-
L117, 33% a-helix), 12 (P113-V123, 27% a-helix, 54% b-sheet), 13 (V123-L133, 27% a-helix, 9% b-sheet, 18% turn), 14 (E134-L149, 25% a-helix, 19%
b-sheet), 15 (L143-L149, 42% b-sheet), and 16 (S150-L156, 57% a-helix). In B, asterisk (*) indicates signiﬁcant difference from the value for the ‘‘None’’
sample (a ¼ 0.05); n ¼ 3 6 SD.
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DISCUSSION
In these studies, protein conformation in amorphous solids
was assessed with the use of FTIR and ssHDX. A comparison
of the results of these twomethods requires an appreciation of
the fundamental bases of the measurements. FTIR measures
the absorption of infrared light that occurs when the fre-
quency of light and the frequency of a vibrational mode of the
protein coincide (27–29). In the amide I region that is often
employed for protein structural analysis (1600–1700 cm1),
the spectrum is dominated by C¼O stretching vibrations of
the protein backbone (27,29). Theoretical analysis indicates
that the C¼O stretching vibrations are most strongly inﬂu-
enced by the interactions of amide dipoles that occur through
space (i.e., transition dipole coupling (TDC)) and by hydro-
gen bonding, although other factors such as through-bond
coupling and the dielectric constant of the medium may also
contribute (27). In computations for an inﬁnite a-helix, the
strongest TDC interactions are with direct neighbors in the
chain and with groups that are hydrogen bonded to the amide
of interest (27). For an antiparallel b-sheet, the strongest
TDC interactions are between peptide groups that are hy-
drogen bonded to one another, or are on different chains, but
in close proximity (27). The C¼O stretching vibrations de-
termined by these interactions are observable because they
are delocalized over large regions of the protein, so that in-
frared light of particular frequencies is absorbed (28). Thus,
FTIR in the amide 1 region measures the absorption of in-
frared light at frequencies corresponding to C¼O stretching
vibrations of the protein, which in turn are determined pri-
marily by through-space interactions (i.e., TDC) and by hy-
drogen bonding.
In solution, an HDX experiment measures the rate and/or
extent of a hydrogen transfer reaction. A typical solution
HDX study involves the exposure of protein in the native
form (‘‘protio’’) to D2O. Hydrogen atoms (
1H) throughout
the molecule are replaced with deuterium (2H) in a reaction
catalyzed by acid, base, and/or water. The exchange of a
particular amide hydrogen for deuterium requires that 1), the
amide hydrogen be accessible to solvent; and 2), the N-H
bond be broken (6,30,31). The reaction is sensitive to protein
structure because amide hydrogen atoms participating in
protein secondary structure (e.g., a-helix and b-sheet) or
buried in the protein core exchange much more slowly than
those that are solvent-exposed (31,32); intrinsic exchange
rate constants (ki) for exposed amide hydrogen atoms are of
FIGURE 5 EC5 conformation in amorphous solids containing various additives (1:1 w/w). (A) Second derivative FTIR spectra. (B) ssHDX of intact protein.
(C) ssHDX of peptic digests. Additives were Tre, Raf, dex, PVA, PVP, and Gdn. In C, peptic fragments and approximate secondary structures were: 1 (P2-F10,
70% b-sheet), 2 (F11-D25, 87% b-sheet), 3 (A26-E38, 38% b-sheet), 4 (L39-W58, 55% b-sheet), 5 (S58-L67, unstructured), 6 (I60-A66, unstructured),
7 (E68-L76, 55% b-sheet), 8 (Y72-L76, 100% b-sheet), 9 (L78-D96, 79% b-sheet), 10 (D96-E111, 6% b-sheet). In B, asterisk indicates signiﬁcant difference
from the value for the ‘‘None’’ sample (a ¼ 0.05); n ¼ 3 6 SD.
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the order 10 s1, whereas those for hydrogen-bonded or core
hydrogen atoms may be reduced by eight orders of magni-
tude or more (31–33). At selected times the reaction may be
quenched by low pH (;2.5) and low temperature (;0C),
which reduces ki by ;10
5 (31), and the samples can be an-
alyzed for deuterium incorporation (e.g., by LC/MS or
NMR). During analysis, deuterium incorporated into the
amino acid side chains undergoes rapid back exchange to the
protio form, whereas deuterium incorporated into backbone
amides is generally retained. Kinetic analysis of HDX in
solution has been used to provide information on protein
dynamics (6).
For HDX in solid samples, it is reasonable to assume that
exchange of a particular amide hydrogen also requires that 1),
the amide hydrogen atom be accessible to D2O; and 2), the
N-H bond be broken. The factors that affect accessibility of
the amide hydrogen in the solid state are likely to differ from
those for solution, however. For example, accessibility of
amide hydrogen atoms in solids may involve D2O vapor
sorption and diffusion of D2O in the solid—processes that
are not relevant in solution. In solution, protein structure
is determined by intramolecular hydrogen bonds (e.g., in
a-helix or b-sheet) and by intermolecular hydrogen bonds to
water. Intermolecular hydrogen bonds certainly contribute to
structure and accessibility in solids, but intramolecular hy-
drogen bonds to water may be ‘‘replaced’’ by hydrogen
bonds to other components of the dry solid (e.g., sugars)
(1,34). The time course of HDX in solution provides infor-
mation about protein dynamics and the relative rates of un-
folding and exchange. In glassy solids, however, the matrix
may restrict the dynamic motions of the protein; thus, the
time required for large-scale motions (e.g., global unfolding)
may be far longer than that for solution, and in fact may be far
longer than the ssHDX experiment. For example, a (i.e.,
global) relaxation times on the order of 105 h have been re-
ported for proteins in glassy solids (35). In addition, there is
growing evidence that amorphous solids are spatially and
dynamically heterogeneous (36,37), and thus exchange may
occur in an ensemble of physical environments. Sequestra-
tion of D2O by excipients is unlikely to be a factor in ssHDX
studies, however, since D2O vapor is in equilibrium with
a relatively large volume D2O solution (see Materials and
Methods).
In this context, we interpret the 72-h percent exchange
values of our ssHDX studies as a pseudo-equilibrium mea-
sure of the accessibility of backbone amide hydrogen atoms
in solid samples to D2O, a value determined primarily by
intra- and intermolecular hydrogen bonds. This is a ‘‘pseudo-
equilibrium’’ measurement, since at ‘‘true’’ equilibrium all
backbone amide hydrogen atoms will be exchanged for deu-
terium, a process that may take years to complete. ssHDX is
similar to FTIR in that both report on backbone amide groups
whose interactions determine protein secondary structure. The
methods differ in that amide I FTIR measures C¼O stretching
vibrations, whereas ssHDX measures the extent of a reaction.
The C¼O stretching vibrations of FTIR are determined
primarily by through-space interactions, hydrogen bonding,
and other factors, as noted above. In contrast, the extent of
ssHDX is likely to be determined primarily by the intra-
and intermolecular hydrogen bonds of the protein in the
solid matrix.
The effects of excipients on the amide I FTIR spectra and
on the extent of ssHDX measured in intact proteins are in
reasonably good agreement for many of the proteins studied
here. For example, the a-helical protein myoglobin shows
FIGURE 6 Con A conformation in amorphous solids containing various
additives (1:1 w/w). (A) Second derivative FTIR spectra. (B) ssHDX of
intact protein. Additives were Tre, Raf, dex, PVA, PVP, and Gdn. In B,
asterisk indicates signiﬁcant difference from the value for the ‘‘None’’
sample (a ¼ 0.05); n ¼ 3 6 SD.
TABLE 3 Comparison of FTIR spectra for formulations
containing excipients to the excipient-free control, using the
‘‘area of overlap’’ method of Kendrick et al. (13); see text
Excipient
Protein 1Tre 1Raf 1Dex 1PVA
Myoglobin 0.94 0.95 0.97 0.92
Lysozyme 0.95 0.97 0.94 0.94
RNase A 0.97 0.96 0.92 0.90
b-Lactoglobulin 0.97 0.98 0.98 0.91
EC5 0.99 0.99 0.99 0.99
Con A 0.97 0.98 0.98 0.98
Table entries are the ratio of the areas of the area-normalized second
derivative spectra; a value of one indicates identical spectra.
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protection from exchange by excipients in the order of tre-
halose, rafﬁnose . dextran . PVA, PVP, none (Fig. 1 B).
With the exception of PVA (discussed below), this order is
consistent with observed decreases in the intensity of the
a-helix band in the FTIR spectrum (1650 cm1, Fig. 1 A).
Proteins with high b-sheet content (i.e., EC-5 and Con A)
also show agreement between excipient effects measured by
the two techniques, although the effects are not as large (Figs.
5 and 6). The poorest agreement between the two methods
is observed for RNase A, a protein with mixed a-helix and
b-sheet content (Table 1). The FTIR spectrum for RNase is
dominated by the strong b-sheet band (1640 cm1); the in-
tensity of this band is increased similarly by all the excipients
relative to the excipient-free control (Fig. 3 A). The weaker
a-helix bands (1650, 1660 cm1) show some differences
among the excipients, with PVA and dextran showing the
greatest effects. In contrast, the ssHDX results show that the
greatest protection from exchange for RNase is provided
by trehalose and rafﬁnose, with minimal effects by dextran
and PVA (Fig. 3 B). These differences may be due to the
propensity of RNase to form oligomers, which have been
routinely produced by lyophilization from acidic solution
(38,39). The RNase FTIR band at 1640 cm1 was assigned to
the b-sheet here and elsewhere (40), but has also been at-
tributed to cross-b structures in RNase oligomers (40). The
dominant FTIR b-sheet band for RNase (Fig. 3 A) may reﬂect
oligomeric species that are relatively insensitive to excipient
selection; weak a-helix bands of the FTIR spectrum provide
limited information on excipient effects in those regions. The
ssHDX results may primarily reﬂect the behavior of the
a-helical domains, which tend to be more excipient-sensitive
(Fig. 3 B) and may be relatively unaffected by oligomer
formation. Oligomeric species were not detected on LC/MS
analysis of RNase samples, suggesting that any oligomers
formed were dissociated during sample preparation and
analysis. For several of the proteins, differences between
FTIR and ssHDX results were observed when PVA was in-
cluded as an excipient (e.g., myoglobin and lysozyme). In-
terpretation of FTIR spectra for PVA may be complicated by
low levels of residual acetate groups that absorb in the amide
I region; PVA is manufactured by hydrolysis of poly(vinyl
acetate). These impurities are not expected to contribute
signiﬁcantly to the ssHDX results.
Analysis of the peptic digests of ssHDX samples provides
a level of structural resolution that cannot be achieved by
FTIR. ssHDX data for digests of myglobin, b-lactoglobulin,
and EC-5 (Figs. 1 C, 4 C, and 5 C) show that protection
from exchange is not conferred uniformly along the protein
backbone, but instead is greatest in fragments corresponding
to structured regions of the proteins. The a-helical fragments
of myoglobin (Fig. 1 C) and b-lactoglobulin (Fig. 4 C) show
the greatest protection from exchange by many of the ex-
cipients, a ﬁnding that is consistent with our previous studies
of the a-helical protein calmodulin (9–11). The b-sheet
fragments of b-lactoglobulin and EC-5 show more limited
protection (Figs. 4 C and 5 C). Although the origins of these
site-speciﬁc effects are unclear, the data suggest that hydro-
gen-bonding interactions between the excipients and the
protein backbone are not involved, since these would be
expected to be greatest in unstructured fragments. As with
solution HDX, the use of immobilized pepsin columns could
be used to improve the ability to digest resistant proteins
(41,42); however, that approach was not attempted here.
In summary, the results demonstrate that ssHDX with ESI/
MS analysis provides information on the structure and inter-
molecular interactions of proteins in amorphous solids. The
technique is complementary to amide I FTIR in that both
methods report on backbone amide groups. The application
of peptic digestion to ssHDX samples provides peptide-level
resolution and has been used to demonstrate that protein-
excipient interactions in the solid state are preferentially
exhibited in structured fragments. ssHDX with ESI/MS
analysis thus shows promise for characterizing proteins in
amorphous solids, with potential applications in the phar-
maceutical, biotechnology, and food industries.
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